Search the Newsreel

Robert Walters Reduces First-Half Loss as Cost Savings and Growth Strategy Deliver Progress

Holista Colltech absorbs ProImmune settlement as cash management tightens

ELTK|Eltek Ltd|Price:8.010|Chg%:-0.650

This article provides a comprehensive stock analysis of Eltek Ltd (ELTK) by TradingKey, highlighting its "relatively healthy" fundamentals and good growth potential. The company is considered fairly valued within the Semiconductors & Semiconductor Equipment industry, despite recent weak stock market performance. Key insights include …

(ELTK) Price Dynamics and Execution-Aware Positioning

This article provides an in-depth analysis of Eltek Ltd. (NASDAQ: ELTK) price dynamics and execution-aware positioning. It highlights a near-term weak sentiment that may lead to a resumption of long-term weakness after a neutral shift, detailing a 65.5:1 risk-reward setup targeting a 15.6% gain …

Valterra Platinum Ltd (AGPPF) Q2 2026 Earnings Call Highlights: Record Revenue Surge and Robust ...

This article first appeared on GuruFocus. Revenue: Increased 93% to ZAR82 billion. EBITDA: Increased to ZAR33.4 billion, with a mining EBITDA margin of 50%. Net Cash: ZAR24 billion at the end of June. Free Cash Flow: ZAR26 billion. Interim Dividend: ZAR15 billion or ZAR57 …

Natural Alternatives International Inc (NAII) Income Statement

This article presents the quarterly and annual income statements for Natural Alternatives International Inc (NAII), offering detailed financial data such as total revenue, cost of revenue, operating expenses, and net income over several fiscal years. It also includes frequently asked questions to guide users …

NAII|Natural Alternatives International Inc|Price:2.250|Chg%:+0.030

This article provides a detailed market analysis for Natural Alternatives International Inc (NAII), highlighting its current stock price, trading strategies, and related analysis. It covers key figures such as market cap, P/E ratios, dividend yield, and stock performance over various periods. The report also …

PulteGroup CEO says housing market is 'pretty good' despite 11% revenue fall

PulteGroup reported strong Q2 2026 earnings, beating estimates with a 6% increase in net new orders, despite an 11% year-over-year revenue decline. CEO Ryan Marshall expressed optimism about the U.S. housing market, citing broad demand across buyer segments and a particularly strong performance in …

Alterity Therapeutics (NASDAQ: ATHE) sets August 31, 2026 expiry for 18.4M ATHO options

Alterity Therapeutics announced that 18,443,495 of its ATHO quoted options will expire on August 31, 2026, at 5:00 PM (AEST). The options are exercisable at $0.50 each, and official quotation on the ASX will cease on August 25, 2026. The company is also advancing …

Valterra Platinum forecasts a staggering 1388% rise in first half headline earnings

VALTERRA PLATINUM LIMITED ORD Z (VALT.L) H1 FY2026 earnings call transcript

India Shelter Finance Q1 Results: Earnings Call Scheduled for Aug 7, 2026

India Shelter Finance Corporation Plans Q1 Earnings Call For August 7

Atal Realtech clarifies Akshay Dhongade resignation reason

Valterra Platinum Achieves 406% EBITDA Growth to R33.4bn in H1 2026 Amid PGM Price Surge and Operational Gains

Valterra Platinum remains ‘highly confident’ in ‘robust outlook’ for PGM demand

Valterra Platinum's Adjusted Earnings Rise on Higher Production, Sales Volumes

Valterra Platinum earnings surge 1 633%, R15bn interim dividend declared

Valterra profit leaps on higher prices, sees AI driving future platinum demand

Why Is Valterra Platinum (LSE:VALT) Rewarding Shareholders Now?

REG - Valterra Platinum Ld - Interim Ordinary Dividend Declaration

Alterity Therapeutics' 18.4 Million Listed Options Set to Expire 31 August 2026

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) has announced that 18,443,495 listed options (ASXC: ATHO) will expire on August 31, 2026, with an exercise price of $0.50 per share. Option holders have until August 25, 2026, to sell their options on the ASX or until …

Alterity Therapeutics Ltd. Revenue Breakdown – HAM:PBN

This article provides a revenue breakdown for Alterity Therapeutics Ltd., trading under the HAM:PBN symbol on the Hamburg Stock Exchange. It highlights the availability of financial data, statements, statistics, and segment performance details for the company on the TradingView platform. The content is primarily …

Alterity Therapeutics Ltd (ATHE) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Alterity Therapeutics Ltd (ATHE), detailing its support, resistance, indicators, and moving averages. It presents a summary of various technical indicators like MACD, RSI, and KDJ, alongside moving average signals. The analysis concludes with a Neutral signal based …

PulteGroup CEO Ryan Marshall: It's a pretty good housing market right now

PulteGroup CEO Ryan Marshall discussed the current state of the housing market during an interview with CNBC's Sara Eisen. He covered various factors impacting the market, including mortgage rates and a new federal housing law. The CEO's comments suggest a positive outlook on the …

PHM|Pultegroup Inc|Price:130.600|Chg%:+1.850

Pultegroup Inc (PHM) has received a relatively healthy stock score from TradingKey, indicating strong fundamentals and high growth potential, though its valuation is noted as fairly valued. The company, a leading homebuilder, shows a high dividend payout ratio and significant institutional ownership, despite a …

Alternative Investment Trust Cancels 3,351 Units in On-Market Buy-Back Program

Alternative Investment Trust Continues On-Market Unit Buy-Back with 3,351 Units Acquired

RailTel Corporation of India Q1 Earnings Conference Call Set for July 31

REG - Valterra Platinum Ld - Interim results and board committee change

Eltek Ltd (ELTK) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for Eltek Ltd (ELTK), noting its current valuation score is 8.17, ranking 53 out of 105 in the Semiconductors & Semiconductor Equipment industry. It highlights the company's P/E ratio of -20.29, which is significantly below its recent high …

Gelteq Ltd (GELS) Valuation: PE, PB & Fair Value Analysis

This article provides a brief valuation analysis for Gelteq Ltd (GELS), focusing on its stock performance and key financial ratios like P/E, P/B, and P/CF. The data indicates that relevant information for these valuation metrics has not yet been disclosed by the company. Gelteq …

Alterity Therapeutics Ltd (ATHE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article discusses the revenue breakdown of Alterity Therapeutics Ltd (ATHE), covering business segments, regional revenue, and profit contribution. However, it states that the relevant data has not been disclosed by the company yet. Therefore, no specific financial details or breakdowns are provided in …

Eltek Ltd (ELTK) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Eltek Ltd (ELTK), detailing its current stock price momentum, support, and resistance levels. It includes a breakdown of various technical indicators like MACD, RSI, and moving averages, offering insights into potential buy, sell, or neutral signals. The …

Pultegroup Inc (PHM) Cash Flow

This article provides a detailed cash flow statement for Pultegroup Inc (PHM), covering quarterly data from FY2013Q1 to FY2026Q2. It presents operating, investing, and financing cash flows, along with related metrics like net income, capital expenditures, and dividends. The information aims to help users …

Gelteq Ltd (GELS) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Gelteq Ltd (GELS), detailing various metrics related to volatility, financial risk, and investment risk. It includes data such as maximum drawdown, realized volatility, return-to-drawdown ratio, and liquidity metrics over different timeframes. The assessment aims to offer insights …